Sermorelin Coupon: $7.20 a Milligram Down to $3.60

Three prices, two denominators, one code. The percentages are the part most pages get slightly wrong, because they measure from whichever base makes the number bigger.

The code is exactly half of the site price, since $72.00 ÷ 2 is $36.00. Against list it is 64.0 %, because $99.99 minus $36.00 is $63.99 and $63.99 ÷ $99.99 is 0.6400. Both figures are honest and they describe different things, so a page quoting one without naming its base is being imprecise rather than generous.

The second denominator matters too. $3.60 divides the discounted price by the 10 mg label. $3.18 divides it by the 11.31 mg that lot 38-01260229 assayed, and that mass is a measurement of one lot on one date rather than a specification any vial inherits.

Here is the sceptical part, and it applies to the whole category rather than to this seller in particular.

If a transaction at $36.00 is sustainable, then $36.00 is close to the market price and $99.99 is a reference point. A list price that almost nobody pays is doing anchoring work: it makes the discounted figure feel like a saving of $63.99 rather than a price of $36.00. The useful defence is to ignore both percentages and compare rates. $3.60 per labelled milligram either beats the alternatives or it does not, and the size of the discount that produced it is irrelevant to that comparison.

The same logic runs the other way when a discount is small. A storefront that never discounts and prices at $40.00 a vial is offering $4.00 per labelled milligram, which is worse than $3.60 despite the absence of theatre. Rates are comparable across storefronts. Percentages are not, because each is measured from a base the seller chose.

Apply that to any coupon you find for this compound elsewhere. Take the final cart total, divide by the labelled mass, and compare that number alone. Our price page runs the same division across every published price point and quantity tier.

Alongside the code there are quantity tiers taking 3 %, 5 % or 10 % off the list price. They are calculated separately, and on this compound they are not competitive.

The best tier is $9.00 per labelled milligram against $3.60 with the code, which is 150 % more per milligram. Chasing a tier by adding vials to a cart therefore increases both the total and the rate, which is the opposite of what a volume discount is supposed to do.

Whether a checkout lets a tier and the code apply together is a cart rule rather than a published one, so treat stacking as something to observe on the order summary rather than plan around. Free carriage starts at $250, and at the code price seven vials total $252.00 and clear it, which is the only combination where buying more improves the landed rate.

Clinic and telehealth pricing runs on a different discount logic, and the arithmetic is harder to check because the denominator is missing.

A membership or subscription price is usually expressed as a percentage off an internal rate, and the internal rate is not published. A 20 % member discount on an unknown base is an unknown number. Worse, it is often attached to a commitment, which converts a one-off price into a recurring one: the honest way to price a twelve-month commitment is to multiply the monthly figure by twelve before comparing it to anything.

None of that reduces to dollars per milligram, because a bundled fee covers an evaluation, prescriber time, laboratory work and a preparation, and no component is itemised in milligrams. That is why our channel comparison leaves the per-milligram column blank for those rows rather than filling it with an estimate.

There is also no copay coupon in the pharmaceutical sense available for this compound, and the reason is structural. Copay cards attach to an approved product with a current label, and there is none here. Any coupon you find is a storefront discount code.

The absence of a copay programme is not evidence of anything sinister, and it is worth explaining properly because it is where the compound's history matters.

Sermorelin was approved and marketed. EMD Serono sold it as Geref under NDA 019863, a diagnostic presentation of 0.05 mg per ampoule with submissions from 1991, and NDA 020443, a therapeutic presentation of 0.5 mg and 1 mg per vial approved on 1997-09-26. Both applications now show a marketing status of Discontinued, and the FDA record carries the Federal Register determination that the product was not discontinued or withdrawn for safety or effectiveness reasons.

With no current US label, there is no marketed brand to run a copay programme, no formulary position and no insurer adjudication. Every price attached to this compound today is a cash price, whether it comes from a research storefront or a clinic. What survives is the compounding route: section 503A permits a pharmacy to work from a bulk substance that was a component of an approved drug product, which is why the prescription route is real here and is not for most compounds sold beside it.

The code changes one number in the transaction and nothing else, which is easy to forget when the number moves by 64 %.

• It does not change the certificate. Lot 38-01260229 reports 99.79 % purity by HPLC-UV-MS across 4 detected peaks and 11.31 mg measured against a 10 mg label. It reports no endotoxin test and no sterility test. A discount applies to the price of the vial, not the scope of the document, and scope is a property of the lot rather than of the vendor.
• It does not change the evidence. PubMed returns 332 records mentioning the compound, 3 with it in the title and zero alongside anti-aging. ClinicalTrials.gov registers no studies naming it. The approvals that existed covered paediatric growth hormone deficiency and pituitary diagnostics.
• It does not add anyone to the transaction. A research listing has no clinician in it at any price.

The correct order of operations is to decide whether the source is acceptable, then apply the code. Deciding in the other order lets a 64 % figure make a judgement that a certificate should have made. If you want the source assessment first, our weighted source ranking scores five channels with the weights fixed in advance.